Ophthalmology

Latest News

Bausch + Lomb Launches Miebo for Dry Eye Disease
Bausch + Lomb Launches Miebo for Dry Eye Disease

September 12th 2023

Miebo, approved in May, addresses tear evaporation in dry eye disease. It will have a wholesale acquisition cost of $771 for a one-month supply.

FDA Issues CRL for Bevacizumab to Treat Wet AMD
FDA Issues CRL for Bevacizumab to Treat Wet AMD

August 30th 2023

FDA Approves Higher Dose Eylea
FDA Approves Higher Dose Eylea

August 21st 2023

FDA Approves Izervay to Treat Geographic Atrophy
FDA Approves Izervay to Treat Geographic Atrophy

August 7th 2023

FDA Rejects Higher Dose of Eylea
FDA Rejects Higher Dose of Eylea

June 28th 2023

More News

© 2023 MJH Life Sciences

All rights reserved.